Product NDC: | 50242-140 |
Proprietary Name: | ERIVEDGE |
Non Proprietary Name: | vismodegib |
Active Ingredient(s): | 150 mg/1 & nbsp; vismodegib |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 50242-140 |
Labeler Name: | Genentech, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA203388 |
Marketing Category: | NDA |
Start Marketing Date: | 20120130 |
Package NDC: | 50242-140-01 |
Package Description: | 1 BOTTLE, PLASTIC in 1 CARTON (50242-140-01) > 28 CAPSULE in 1 BOTTLE, PLASTIC |
NDC Code | 50242-140-01 |
Proprietary Name | ERIVEDGE |
Package Description | 1 BOTTLE, PLASTIC in 1 CARTON (50242-140-01) > 28 CAPSULE in 1 BOTTLE, PLASTIC |
Product NDC | 50242-140 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | vismodegib |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 20120130 |
Marketing Category Name | NDA |
Labeler Name | Genentech, Inc. |
Substance Name | VISMODEGIB |
Strength Number | 150 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Hedgehog Pathway Inhibitor [EPC],Smoothened Receptor Antagonists [MoA] |